These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32514646)

  • 21. PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
    Nakano H; Saito M; Nakajima S; Saito K; Nakayama Y; Kase K; Yamada L; Kanke Y; Hanayama H; Onozawa H; Okayama H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Goto A; Kono K
    Sci Rep; 2021 Jan; 11(1):1982. PubMed ID: 33479394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma.
    Zhou H; Tan S; Li H; Lin X
    Mol Med Rep; 2019 Mar; 19(3):2125-2136. PubMed ID: 30747208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
    Moore A; Hikri E; Goshen-Lago T; Barkan T; Morgenstern S; Brook E; Maderer A; Roth W; Gordon N; Kashtan H; Brenner B; Moehler M; Aharon IB
    BMC Cancer; 2020 Jan; 20(1):34. PubMed ID: 31937281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
    Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
    Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations.
    Abe H; Kaneda A; Fukayama M
    Pathobiology; 2015; 82(5):212-23. PubMed ID: 26337667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
    Choi S; Kim H; Heo YJ; Kang SY; Ahn S; Lee J; Kim KM
    J Pathol; 2023 Aug; 260(4):443-454. PubMed ID: 37341658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma.
    Okabe A; Huang KK; Matsusaka K; Fukuyo M; Xing M; Ong X; Hoshii T; Usui G; Seki M; Mano Y; Rahmutulla B; Kanda T; Suzuki T; Rha SY; Ushiku T; Fukayama M; Tan P; Kaneda A
    Nat Genet; 2020 Sep; 52(9):919-930. PubMed ID: 32719515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
    Fukayama M; Kunita A; Kaneda A
    Adv Exp Med Biol; 2018; 1045():437-457. PubMed ID: 29896679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus and gastric carcinoma.
    Fukayama M
    Pathol Int; 2010 May; 60(5):337-50. PubMed ID: 20518883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
    Abe H; Kunita A; Otake Y; Kanda T; Kaneda A; Ushiku T; Fukayama M
    PLoS One; 2021; 16(9):e0256440. PubMed ID: 34469459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2.
    Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F
    J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis.
    Camargo MC; Murphy G; Koriyama C; Pfeiffer RM; Kim WH; Herrera-Goepfert R; Corvalan AH; Carrascal E; Abdirad A; Anwar M; Hao Z; Kattoor J; Yoshiwara-Wakabayashi E; Eizuru Y; Rabkin CS; Akiba S
    Br J Cancer; 2011 Jun; 105(1):38-43. PubMed ID: 21654677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
    Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
    Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
    Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
    Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma.
    Moon JW; Kong SK; Kim BS; Kim HJ; Lim H; Noh K; Kim Y; Choi JW; Lee JH; Kim YS
    Sci Rep; 2017 Dec; 7(1):17810. PubMed ID: 29259270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
    Cho J; Kim E; Yoon SE; Kim SJ; Kim WS
    Cancer; 2023 May; 129(10):1502-1512. PubMed ID: 36812290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
    Derks S; Liao X; Chiaravalli AM; Xu X; Camargo MC; Solcia E; Sessa F; Fleitas T; Freeman GJ; Rodig SJ; Rabkin CS; Bass AJ
    Oncotarget; 2016 May; 7(22):32925-32. PubMed ID: 27147580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease?
    Jácome AA; Lima EM; Kazzi AI; Chaves GF; Mendonça DC; Maciel MM; Santos JS
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):150-7. PubMed ID: 27192582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
    Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
    Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on Epstein-Barr virus and gastric cancer (review).
    Shinozaki-Ushiku A; Kunita A; Fukayama M
    Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.